Cellular basis of cardiac dysrhythmias.
D000200:Action Potentials / Q000187:drug effects*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001572:Benzofurans / Q000627:therapeutic use; D001949:Bretylium Compounds / Q000627:therapeutic use; D002463:Cell Membrane Permeability / Q000187:drug effects*; D004983:Ethanolamines / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006801:Humans; D007037:Hypothyroidism; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy
D001572:Benzofurans; D001949:Bretylium Compounds; D004983:Ethanolamines; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine